Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greta Alì

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Lung Cancer (Amsterdam, Netherlands)|October 14, 2019
Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experienceMarco Chiappetta, Edoardo Zanfrini, Luca Giraldi, et al.
Pathologica|September 18, 2025
Part I - Pre-analytical phaseCaterina Marchiò, Enrico Berrino, Stefania Scarpino, et al.
Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2019
Crizotinib in <i>MET</i>-Deregulated or <i>ROS1</i>-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms TrialLorenza Landi, Rita Chiari, Marcello Tiseo, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Diagnostics of <i>BAP1</i>-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long ExperienceMarika Sculco, Marta La Vecchia, Anna Aspesi, et al.
Cancers|October 13, 2021
Automated Analysis of Proliferating Cells Spatial Organisation Predicts Prognosis in Lung Neuroendocrine NeoplasmsMatteo Bulloni, Giada Sandrini, Irene Stacchiotti, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2025
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS databaseMaria Lucia Reale, Daniela Scattolin, Antonio Vitale, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2025
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas databaseClaudio Sini, Alessandro Russo, Diego Cortinovis, et al.
Cancer Cytopathology|January 10, 2022
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter studyElena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Lung Cancer (Amsterdam, Netherlands)|October 14, 2019
Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experienceMarco Chiappetta, Edoardo Zanfrini, Luca Giraldi, et al.
Pathologica|September 18, 2025
Part I - Pre-analytical phaseCaterina Marchiò, Enrico Berrino, Stefania Scarpino, et al.
Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2019
Crizotinib in <i>MET</i>-Deregulated or <i>ROS1</i>-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms TrialLorenza Landi, Rita Chiari, Marcello Tiseo, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Diagnostics of <i>BAP1</i>-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long ExperienceMarika Sculco, Marta La Vecchia, Anna Aspesi, et al.
Cancers|October 13, 2021
Automated Analysis of Proliferating Cells Spatial Organisation Predicts Prognosis in Lung Neuroendocrine NeoplasmsMatteo Bulloni, Giada Sandrini, Irene Stacchiotti, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2025
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS databaseMaria Lucia Reale, Daniela Scattolin, Antonio Vitale, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2025
Braf-mutant metastatic non-small-cell lung cancer: Real world data from the Italian biomarker atlas databaseClaudio Sini, Alessandro Russo, Diego Cortinovis, et al.
Cancer Cytopathology|January 10, 2022
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter studyElena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, et al.
Pageof 10